COMPASS Pathways Plc
Last updated September 27, 2026
Organization details
- Legal name
- COMPASS Pathways Plc
- Former names
- Compass Rx Ltd.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Year founded
- 2020
- Jurisdiction of incorporation
- United Kingdom
- Headquarters city
- Chesire
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- CMPS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001816590
- UK company number
- 12696098
- Wikidata ID
- Q56481140
Board of directors
-
Annalisa Jenkins · DirectorSince 2023
-
Daphne Karydas · DirectorSince 2023
-
Daphne Karydas · DirectorSince 2023
-
David Y. Norton · DirectorSince 2023
-
David York Norton · DirectorSince 2020
-
Ekaterina Malievskaia · Director · Chief Innovation OfficerSince 2023
-
George Jay Goldsmith · DirectorSince 2023
-
Gino Santini · DirectorSince 2024
-
Gino Santini · DirectorSince 2024
-
Jeffrey M. Jonas · DirectorSince 2025
-
Jeffrey, Jonas · DirectorSince 2025
-
Justin D. Gover · DirectorSince 2025
-
Justin Gover · DirectorSince 2025
-
Kabir Kumar Nath · DirectorSince 2022
-
Kabir Nath · Director · Chief Executive OfficerSince 2023
-
Kathleen Tregoning · DirectorSince 2026
-
Kathleen Tregoning · DirectorSince 2026
-
Linda McGoldrick · DirectorSince 2023
-
Phd, Robert Dwyer McQuade · DirectorSince 2020
-
Robert McQuade · DirectorSince 2023
-
Thomas Lonngren · DirectorSince 2023
-
Wayne Joseph Riley · DirectorSince 2023
-
Wayne Joseph Riley · DirectorSince 2021
Former directors
-
Annalisa Jenkins · Director2020 – 2026
-
Ekaterina, Malievskaia · Director2020 – 2024
-
Florian Brand · Director2020 – 2021
-
George Jay Goldsmith · Director2020 – 2024
-
Jason, Camm · Director2020 – 2022
-
Linda McGoldrick · Director2020 – 2025
-
Piers John Morgan · Director2020 – 2020
-
Thomas Lonngren · Director2020 – 2025
Chief executives
Kabir Nath
· Chief Executive Officer
Dates unknown
Board connections
6 of this board's directors also sit on 10 other boards. 10 are in the same sector.
-
Collegium Pharmaceutical Inc. Same sectorvia Gino Santini
-
Design Therapeutics Inc. Same sectorvia Justin D. Gover
-
HCA Healthcare Inc. Same sectorvia Wayne Joseph Riley
-
Heartflow Inc. Same sectorvia Wayne Joseph Riley
-
Mereo BioPharma Group plc Same sectorvia Annalisa Jenkins
-
Mineralys Therapeutics Inc. Same sectorvia Daphne Karydas
-
Skye Bioscience Inc. Same sectorvia Annalisa Jenkins
-
Spero Therapeutics Inc. Same sectorvia Kathleen Tregoning
-
Tectonic Therapeutic Inc. Same sectorvia Annalisa Jenkins
-
Xenon Pharmaceuticals Inc. Same sectorvia Justin D. Gover
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −5,962 | $11.25 | $67,073 |
| Mar 26, 2026 | Kabir Nath Director, Officer (Chief Executive Officer) | Grant or award | +175,000 | — | — |
| Mar 26, 2026 | Teri Loxam Officer (Chief Financial Officer) | Grant or award | +75,000 | — | — |
| Mar 11, 2026 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −13,131 | $6.89 | $90,473 |
| Mar 11, 2026 | Teri Loxam Officer (Chief Financial Officer) | Shares withheld for tax | −1,781 | $6.89 | $12,271 |
| Mar 2, 2026 | Teri Loxam Officer (Chief Financial Officer) | Shares withheld for tax | −4,467 | $7.02 | $31,358 |
| Feb 2, 2026 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −16,181 | $6.61 | $106,956 |
| Aug 1, 2025 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −6,366 | $4.34 | $27,628 |
| Mar 11, 2025 | Teri Loxam Officer (Chief Financial Officer) | Grant or award | +25,000 | — | — |
| Mar 11, 2025 | Kabir Nath Director, Officer (Chief Executive Officer) | Grant or award | +92,000 | — | — |
| Mar 3, 2025 | Teri Loxam Officer (Chief Financial Officer) | Shares withheld for tax | −4,468 | $3.67 | $16,398 |
| Feb 3, 2025 | Kabir Nath Director, Officer (Chief Executive Officer) | Shares withheld for tax | −15,516 | $4.31 | $66,874 |
| Oct 24, 2024 | Ekaterina Malievskaia 10% owner | Open-market sale | −776,565 | — | — |
| Oct 24, 2024 | George Jay Goldsmith 10% owner | Open-market sale | −776,565 | — | — |
| Oct 24, 2024 | Ekaterina Malievskaia 10% owner | Open-market sale | −776,565 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Akanda Corp.
Nasdaq: AKAN · New Romney, United Kingdom
Organization
Akari Therapeutics plc
Nasdaq: AKTX · Tampa, United Kingdom
Organization
AstraZeneca PLC
NYSE: AZN · Cambridge, United Kingdom
Organization
Autolus Therapeutics plc American Depositary Share
Nasdaq: AUTL · London, United Kingdom
Organization
Questions about COMPASS Pathways Plc
Who is the CEO of COMPASS Pathways Plc?
Kabir Nath is COMPASS Pathways Plc's Chief Executive Officer.
How many directors are on COMPASS Pathways Plc's board?
COMPASS Pathways Plc's board has 23 directors: Annalisa Jenkins, Daphne Karydas, Daphne Karydas, David Y. Norton, David York Norton, Ekaterina Malievskaia, George Jay Goldsmith, Gino Santini, Gino Santini, Jeffrey M. Jonas and 13 others.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="compass-pathways-plc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.